Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Shares Outstanding (Weighted Average): 2015-2024

Historic Shares Outstanding (Weighted Average) for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to $16.8 million.

  • Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) rose 114.09% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 114.09%. This contributed to the annual value of $16.8 million for FY2024, which is 103.49% up from last year.
  • Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) amounted to $16.8 million in FY2024, which was up 103.49% from $8.3 million recorded in FY2023.
  • In the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) registered a high of $16.8 million during FY2024, and its lowest value of $3.4 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $10.4 million, with a median of $8.3 million in 2023.
  • Data for Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) shows a peak YoY surged of 103.49% (in 2024) over the last 5 years.
  • Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) (Yearly) stood at $3.4 million in 2020, then spiked by 37.15% to $4.6 million in 2021, then grew by 29.33% to $6.0 million in 2022, then surged by 38.72% to $8.3 million in 2023, then spiked by 103.49% to $16.8 million in 2024.